Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use

US Patent 11524009 · Granted Dec 13, 2022

Assignee

Inventors

View full patent text on Google Patents →